Image Alt
News & Media


Nano2Clinic – Synergies for Clinical Translation of Nanotechnology in Cancer Therapies

Nanotechnologies fundamentally change the current therapies and enable development of novel treatments and diagnostic approaches. The improvements in medical therapies and diagnostic achieved through innovative medical nanoproducts has a great and direct clinical importance and provide benefits for the patients. Hence, best practices in design and development of such nanoproducts will contribute to societal prosperity and welfare, by providing access to better and safer treatments.

This meeting aims to strengthen relations between industry, R&D&I sector, regulatory agencies, clinics, and patients with the ultimate goal of fostering the clinical translation of nanomedicine from bench to bedside. By promoting scientific exchanges, technological implementation and innovative solutions, the meeting will enable dialogue for rationalizing and focusing research efforts at the EU level in dealing with the grand challenge of nanomedicine translation for cancer therapies.

There is no registration fee for this event but the number of attendees is limited. Please register by 20 February 2023.

Školska Knjiga d.d. (Main Aula)
Masarykova 28